Last reviewed · How we verify

NCT04763239

Prognostic Significance of Red Blood Cell

Completed Last updated 29 August 2022
What this trial tests

trial in Critical Illness in 111 participants. Completed in 1 August 2022.

Timeline
1 March 2021
Primary endpoint
1 June 2022
1 August 2022

Quick facts

Lead sponsorSohag University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment111
Start date1 March 2021
Primary completion1 June 2022
Estimated completion1 August 2022
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

Adults 1 Month to 12, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Red blood cell (RBC) distribution width (RDW), calculated by dividing the standard deviation of RBC volume by the mean corpuscular volume and multiplied by 100, is routinely reported as part of the complete blood count (CBC) using automated flow cytometry. RDW has been traditionally used as additional information in the differential diagnosis of the cause of anemia. RDW has been recently reported as a strong prognostic factor in several diseases of various organ systems, including the cardiovascular, respiratory, renal, neurologic, and gastrointestinal systems.It also showed significant associations with ventilator-free days, postoperative outcome, intensive care unit (ICU) discharge outcome, out-of-hospital outcome, and all-cause mortality in critically ill patients. However, most studies were conducted in adult patients. Only a few studies have investigated RDW in children, especially in the critically ill pediatric population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04763239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing